Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 041127/0361 | |
| Pages: | 17 |
| | Recorded: | 12/21/2016 | | |
| Attorney Dkt #: | 2923-1313 AND 2923-961 |
| Conveyance: | MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12516682
|
Filing Dt:
|
05/28/2009
|
|
Publication #:
|
|
Pub Dt:
|
02/25/2010
| | | | |
|
Title:
|
ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/30/2019
|
Application #:
|
15047041
|
Filing Dt:
|
02/18/2016
|
|
Publication #:
|
|
Pub Dt:
|
06/09/2016
| | | | |
|
Title:
|
ACTIVATED HER3 AS A MARKER FOR PREDICTING THERAPEUTIC EFFICACY
|
|
|
Assignor
|
|
|
|
|
|
Newly Merged Entity Data
|
|
|
|
|
|
Newly Merged Entity's New Name
|
|
|
|
|
| ZIELSTATTSTR.48 |
| MÜNCHEN, GERMANY 81379 |
|
|
Correspondence name and address
|
| |
ROTHWELL, FIGG, ERNST & MANBECK, P.C.
|
| |
607 14TH STREET, N.W.
|
| |
SUITE 800
|
| |
WASHINGTON, DC 20005
|
Search Results as of:
05/29/2024 02:32 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
